Company: SCLXW
Filing Date: 2025-12-29
Form Type: 424B3
Source: 0001193125-25-335429
Chunk: 195

Company: Scilex Holding Co
Filing Date: 2025-12-29
Form: 424B3
Chunk 195
---
 dividends and
splits, the number of shares of Common Stock issuable upon the exercise of the Exchange Warrants will also be adjusted so that the aggregate exercise price shall be the same immediately before and immediately after any such adjustment.

Cashless Exercise

If at the time of
exercise of the Exchange Warrants, there is no effective registration statement registering the shares of our Common Stock underlying the Exchange Warrants, such warrants may be exercised on a cashless basis pursuant to their terms.

Limitations on Exercise

A holder shall
not have the right to exercise any portion of an Exchange Warrant to the extent that, after giving effect to such conversion, the holder (together with certain of its related parties) would beneficially own in excess of the Exchange Warrant Maximum
Percentage of 4.99% of shares of our Common Stock outstanding immediately after giving effect to such exercise. The Exchange Warrant Maximum Percentage may be raised or lowered to any other percentage not in excess of 9.99%, at the option of the
holder, except that any increase will only be effective upon 61 days’ prior notice to us.

Exercise Period

The Exchange Warrants were immediately exercisable upon issuance, and will be exercisable until the Exchange Warrant expiration date of
October 8, 2029.

Purchase and Distribution Rights

If we (i) issue or sell options, convertible securities or rights to purchase stock, warrants, securities or other property (collectively,
“Purchase Rights”) pro rata to the record holders of our common stock or (ii) declare or

123

make any dividend or other distribution of or assets (or rights to acquire our assets) to holders of our Common Stock, by way of return of capital or otherwise (“Distribution”), then,
in each case, a holder of Exchange Warrants will, upon each exercise of an Exchange Warrant, be entitled to participate in such issuance or sale of Purchase Rights or Distribution, as applicable, to the same extent that the holder would have
participated therein if the holder had held the number of shares of our Common Stock the holder acquired upon each such exercise immediately before the date on which a record is taken for such issuance or sale of Purchase Rights or Distribution.

Fundamental Transactions

The
Exchange Warrants prohibit us from entering into specified fundamental transactions unless the successor entity (subject to certain exceptions) assumes all of our obligations under the Exchange Warrants under a written agreement before the
transaction is completed and the successor entity is a publicly traded company.

Upon specified corporate